One-quarter of COVID-19 patients developed PTSD symptoms: A one-year longitudinal study.

ABSTRACT: This study investigated the longitudinal development of PTSD symptoms and respiratory sequelae among COVID-19 patients one year after hospital discharge. The cumulative occurrence of probable PTSD in COVID-19 survivors (n = 329) was 26.7%, which significantly decreased over the 12-month period (23.1% to 4.3%). Non-severe patients showed marked improvement in all four clusters of PTSD symptoms at 12 months compared to 3 months, while severe patients only showed improvements in re-experiencing and numbing symptoms. Moreover, being female and having respiratory sequelae increased the risk for chronic PTSD. Psychological interventions are required for COVID-19 patients during long-term convalescence.

SUBMITTER: Sun L 

PROVIDER: S-EPMC10011031 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature